Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

C3_MGUS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — D47.2 Hospital discharge: ICD-10 — D47.2 Hospital discharge: ICD-9 — 2731 Cause of death: ICD-10 — D47.2 Cause of death: ICD-9 — 2731 Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 9765 Cancer registry: Behaviour codes — 1 4 out of 7 registries used, show all original rules.	2327
4. Check minimum number of events None	2327
5. Include endpoints None	2327
6. Filter based on genotype QC (FinnGen only)	1890

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_MGUS_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	D472
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D472
HD_ICD_9	2731
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D472
COD_ICD_9	2731
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	9765
CANC_MORPH_EXCL
CANC_BEHAV	1

Similar endpoints

↥

List of similar endpoints to Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1890	858	1032
Unadjusted period prevalence (%)	0.40	0.30	0.47
Median age at first event (years)	70.85	69.43	72.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1961: Matched controls
19610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C90.0

ICD-10 Finland

Multiple myeloma

+∞

307.7

348

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

+∞

307.7

1950

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

298.1

307.7

403

H02AB02

ATC

dexamethasone; systemic

35.7

307.7

319

106

XW000

NOMESCO Finland

Bone marrow biopsy

64.1

307.7

792

205

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

66.6

300.2

165

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

56.6

250.9

142

AA1AA

NOMESCO Finland

Head X-ray examination

34.3

242.0

155

JN4AD

NOMESCO Finland

Body CT examination

7.2

234.2

398

673

A04AA01

ATC

ondansetron; systemic, rectal

12.0

222.6

236

221

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

213.5

201

153

Kela drug reimbursment

Lenalidomid

+∞

178.9

169

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

10.2

178.4

210

227

L04AX04

ATC

lenalidomide; oral

+∞

174.6

165

C61

ICD-10 Finland

Malignant neoplasm of prostate

449.9

168.3

166

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

437.9

164.1

162

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

82.7

163.7

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

161.7

153

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.5

159.6

477

1310

JN4BD

NOMESCO Finland

Extensive body CT

6.5

148.8

263

455

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

1508.2

144.6

139

WF002

NOMESCO Finland

Radical radiotherapy

56.3

143.1

329

Kela drug reimbursment

Lenalidomide

+∞

142.5

135

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

138.2

131

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.1

135.5

319

717

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

56.4

134.3

D64.9

ICD-10 Finland

Anaemia, unspecified

3.9

131.6

490

1560

B03XA02

ATC

darbepoetin alfa; parenteral

11.7

128.6

135

123

L03AA02

ATC

filgrastim; parenteral

231.9

127.4

130

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

126.3

954

4651

WW500

NOMESCO Finland

Blood transfusion

9.7

117.9

142

157

ZX112

NOMESCO Finland

Subcutaneous

22.4

116.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

114.7

1283

7605

L02AE02

ATC

leuprorelin; implant, parenteral

65.1

114.2

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.0

113.1

160

216

130

Kela drug reimbursment

Malignant tumour

+∞

110.5

105

ZX120

NOMESCO Finland

Intravenous

4.5

101.5

273

678

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

98.8

116

Kela drug reimbursment

Prostate cancer

+∞

97.7

WZC00

NOMESCO Finland

Treatment plan or consultation

2.7

95.8

748

3593

Z51.5

ICD-10 Finland

Palliative care

4.9

95.4

228

514

R50.9

ICD-10 Finland

Fever, unspecified

3.3

95.0

443

1601

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.9

90.0

171

314

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

89.5

367

1221

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.8

86.5

207

466

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

86.3

359

1204

B03XA01

ATC

erythropoietin; parenteral

19.2

82.4

N02AA05

ATC

oxycodone; systemic

2.9

81.9

502

2101

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.8

79.9

193

437

PJA12

NOMESCO Finland

Sentinel node biopsy

799.5

78.9

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

799.5

78.9

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

799.5

78.9

M04AA01

ATC

allopurinol; systemic

2.9

77.6

470

1949

H02AB06

ATC

prednisolone; systemic

2.4

74.0

1119

7064

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

259.8

73.9

D75.2

ICD-10 Finland

Essential thrombocytosis

34.4

73.8

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

376.0

73.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

72.2

365

1366

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

72.1

304

1021

XX3DW

NOMESCO Finland

Time consuming IT work

4.5

69.0

181

437

HAB40

NOMESCO Finland

Wedge excision of mammary gland

23.3

68.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

338.2

65.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

65.9

764

4252

115

Kela drug reimbursment

Breast cancer

+∞

65.0

C03CA01

ATC

furosemide; systemic

2.2

64.5

946

5785

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.7

63.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.7

62.5

101

157

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

62.4

550

2706

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

62.1

294

1054

A02BC02

ATC

pantoprazole; systemic

2.4

60.6

1472

10921

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.9

60.2

138

298

J01MA12

ATC

levofloxacin; systemic

2.5

59.9

484

2283

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

59.7

J05AB01

ATC

aciclovir; systemic

2.4

59.5

528

2598

B01AB05

ATC

enoxaparin; parenteral

2.2

59.5

715

4002

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

57.5

739

4238

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

574.2

56.9

ZX108

NOMESCO Finland

Inhalation

16.4

56.5

M05BX04

ATC

denosumab; parenteral

3.6

56.0

201

606

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

55.8

506

2504

L01AA03

ATC

melphalan; systemic

+∞

55.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.0

54.9

172

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

553.0

54.8

L03AA13

ATC

pegfilgrastim; parenteral

284.0

54.5

B01AB10

ATC

tinzaparin; parenteral

3.1

53.9

248

871

A11CC03

ATC

alfacalcidol; systemic

5.5

53.7

107

204

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

53.5

179

514

L01XX05

ATC

hydroxycarbamide; oral

68.6

52.4

JN4CD

NOMESCO Finland

Very extensive body CT

7.5

51.9

103

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.8

51.7

168

473

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

51.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

50.7

230

800

WW300

NOMESCO Finland

Transfer of autologic stem cells

510.7

50.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

49.0

322

1365

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

48.7

333

1440

A04AA02

ATC

granisetron; systemic, transdermal

70.6

48.3

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

48.1

TK800

NOMESCO Finland

Hemodialysis

5.8

47.6

160

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.2

47.5

101

204

Z3231

NOMESCO Finland

Registered nurse

2.1

47.3

600

3374

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.1

46.8

100

203

L57.0

ICD-10 Finland

Actinic keratosis

2.8

46.2

268

1065

UJF32

NOMESCO Finland

Coloscopy

2.1

46.0

615

3520

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

44.7

252

986

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

43.9

GD1AD

NOMESCO Finland

Thorax CT examination

3.3

43.8

179

584

D70.89

ICD-10 Finland

Neutropenic splenomegaly

12.1

43.8

L02BB03

ATC

bicalutamide; oral

+∞

42.9

N03AX16

ATC

[U] pregabalin

2.1

42.8

530

2935

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

42.6

110

261

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.9

42.6

204

R4110

NOMESCO Finland

Physiotherapy

2.0

42.5

599

3477

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

115.1

41.9

KCD02

NOMESCO Finland

Transurethral resection of bladder

14.3

41.7

N02AX02

ATC

tramadol; systemic, rectal

1.9

41.7

919

6203

ZXE00

NOMESCO Finland

One hour or less

1.9

41.0

766

4890

WX402

NOMESCO Finland

General anaesthesia

2.2

40.7

398

2005

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

40.6

268

1133

HA1AA

NOMESCO Finland

X-ray mammography

4.4

40.4

104

246

WF003

NOMESCO Finland

Adjuvant radiotherapy

209.3

40.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

39.9

514

2878

393

Kela drug reimbursment

Pomalidomide

+∞

39.7

Z2221

NOMESCO Finland

Medical doctor

2.0

39.3

550

3172

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

39.1

191

690

J01DB01

ATC

cefalexin; oral

2.2

39.0

1599

13133

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

+∞

38.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

38.5

563

3292

Y77

ICPC

Malignant neoplasm prostate

198.8

37.9

L04AX06

ATC

pomalidomide; oral

+∞

37.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

37.3

281

1261

WF004

NOMESCO Finland

Palliative radiotherapy

374.2

37.1

WZC30

NOMESCO Finland

Teaching

2.3

37.0

310

1459

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

36.8

295

1362

1507

Kela drug reimbursment

Pomalidomide

+∞

35.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

35.5

711

4591

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

353.4

35.1

A12AA04

ATC

calcium carbonate; oral

5.8

34.8

113

JN6AD

NOMESCO Finland

CT of torso and neck

9.5

34.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

34.5

L28

ICPC

Limited function/disability (L)

1.9

34.4

540

3216

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.7

34.3

179

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.0

34.1

156

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.8

34.1

J01MA14

ATC

moxifloxacin; systemic

2.6

34.0

222

930

N02BE01

ATC

paracetamol; systemic, rectal

2.5

34.0

1768

15367

S18

ICPC

Laceration/cut

1.8

33.7

979

7038

ZZR00

NOMESCO Finland

Flap of skin

11.5

33.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.5

33.0

119

358

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

32.9

153

537

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.7

32.8

L02BG04

ATC

letrozole; oral

49.7

32.6

Z3226

NOMESCO Finland

Physiotherapist

2.1

32.4

390

2112

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

8.7

32.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

32.3

465

2682

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

32.1

505

3000

127

Kela drug reimbursment

Transplant complication

7.9

32.0

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

73.5

31.9

G62.8

ICD-10 Finland

Other specified polyneuropathies

7.1

31.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.4

31.4

115

349

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.1

30.8

136

463

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

111.9

30.7

WW200

NOMESCO Finland

Immunization

4.5

30.6

175

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

30.4

415

2344

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

30.3

J05AB11

ATC

valaciclovir; oral

2.1

29.8

308

1571

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

29.6

112

347

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.9

29.6

241

R53

ICD-10 Finland

Malaise and fatigue

1.8

29.6

549

3424

L04AA06

ATC

mycophenolic acid; systemic

5.6

29.5

102

AA1AD

NOMESCO Finland

CT of head and brain

1.8

29.5

733

4983

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.6

29.3

183

749

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

29.2

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

29.2

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

28.9

245

1152

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.7

28.8

146

A28

ICPC

Limited function/disability NOS

1.8

28.8

516

3181

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

28.6

154

585

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

28.4

183

760

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

28.3

113

362

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

28.2

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

28.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

28.2

R4190

NOMESCO Finland

Nutritional therapy

4.5

27.9

154

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.1

27.7

E0000UV, ,

ATC

1.7

27.5

795

5606

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

27.3

454

2728

D64.8

ICD-10 Finland

Other specified anaemias

4.3

27.2

170

L01FC01

ATC

daratumumab; parenteral

+∞

27.1

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

27.1

398

Kela drug reimbursment

Ixazomib

+∞

27.1

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

27.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

27.0

279

1419

N19

ICD-10 Finland

Unspecified kidney failure

2.9

27.0

135

493

M05BA04

ATC

alendronic acid; oral

2.2

26.8

250

1221

HAC20

NOMESCO Finland

Total mastectomy

76.3

26.8

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

274.7

26.8

C50.99

ICD-10 Finland

Breast, unspecified

274.7

26.8

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

274.7

26.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

26.8

727

5032

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

26.7

768

5397

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

26.7

245

1189

P01BA02

ATC

hydroxychloroquine; oral

2.4

26.6

196

866

E85.9

ICD-10 Finland

Amyloidosis, unspecified

25.1

26.6

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

26.5

142

538

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

26.4

1266

10156

E83.50

ICD-10 Finland

Hypercalcemia

5.7

26.2

1505

Kela drug reimbursment

Ixazomib

+∞

26.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

26.1

923

6836

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

264.0

25.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

25.4

331

1831

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

25.1

337

1882

UKC02

NOMESCO Finland

Cystoscopy

1.9

25.0

371

2141

WVA20

NOMESCO Finland

Medicine administration

3.8

24.9

204

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

24.8

503

3195

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

24.8

262

1342

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

253.3

24.7

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

253.3

24.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

24.7

197

901

J01CA04

ATC

amoxicillin; systemic

1.8

24.4

1492

12629

ZX090

NOMESCO Finland

Other technic of radiotherapy

49.0

24.3

WZC15, ,

NOMESCO Finland

49.0

24.3

XKD00

NOMESCO Finland

Uroflowmetry

1.9

24.3

359

2068

R80

ICD-10 Finland

Isolated proteinuria

6.8

24.3

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

7.7

24.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.0

24.2

106

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

24.2

708

4968

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

24.1

154

636

C08CA01

ATC

amlodipine; oral

1.6

24.0

936

7050

B82

ICPC

Anaemia other/unspecified

3.2

24.0

308

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

24.0

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

20.9

23.9

R06.0

ICD-10 Finland

Dyspnoea

1.7

23.9

628

4281

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

23.8

354

2043

H02AB04

ATC

methylprednisolone; systemic

1.9

23.7

322

1803

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.0

23.7

175

ZXD05

NOMESCO Finland

Urgent procedure

1.7

23.6

585

3923

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.1

23.3

H02AB07

ATC

prednisone; oral

2.0

23.2

299

1644

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

54.7

23.1

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

25.0

23.1

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

23.0

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

23.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

23.0

A04AA55

ATC

palonosetron, combinations; systemic

+∞

23.0

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

23.0

L04AD01

ATC

ciclosporin; systemic

5.1

22.9

ZXA05

NOMESCO Finland

Left side

1.7

22.8

511

3329

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.5

22.6

233

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

22.5

258

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

22.5

800

5863

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.1

22.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

22.5

136

547

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

22.4

308

1729

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

22.2

281

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

8.0

22.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

22.2

454

2881

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

22.1

254

1339

E85.89

ICD-10 Finland

Other amyloidosis

52.6

22.1

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.5

22.0

119

9671/3-C42.1

ICD-O-3

Lymphoplasmacytic lymphoma of bone marrow

+∞

21.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

21.9

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

21.9

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

21.9

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

21.9

376

2265

J01MA02

ATC

ciprofloxacin; systemic

1.6

21.8

783

5741

D45

ICD-10 Finland

Polycythaemia vera

39.1

21.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

21.7

102

360

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

116.3

21.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

21.6

109

400

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

21.5

151

L04AX03

ATC

methotrexate; systemic

2.1

21.4

211

1051

NK6AN

NOMESCO Finland

Total body bone isotope imaging

26.7

21.4

A06AH03

ATC

naloxegol; oral

7.9

21.3

C07AB07

ATC

bisoprolol; oral

1.6

21.3

1143

9186

C03DA01

ATC

spironolactone; oral

1.9

21.3

333

1948

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

21.0

331

1939

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

20.9

345

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

60.7

20.9

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

60.7

20.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

20.9

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

20.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.1

20.8

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

37.6

20.8

3AC01, ,

NOMESCO Finland

6.2

20.7

A06AD11

ATC

lactulose; oral

1.8

20.6

359

2167

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

212.2

20.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

20.6

569

3900

L02BA01

ATC

tamoxifen; oral

111.2

20.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

20.4

153

680

N03AX12

ATC

[U] gabapentin; oral

1.8

20.2

345

2071

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

20.0

321

N06AX21

ATC

duloxetine; oral

2.0

19.9

234

1243

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

36.1

19.8

1XX32, ,

NOMESCO Finland

+∞

19.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

19.8

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

19.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

19.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

106.1

19.6

J01FF01

ATC

clindamycin; systemic

1.7

19.6

516

3488

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

19.4

156

714

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

19.4

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.7

19.3

108

418

A02BC01

ATC

omeprazole; systemic

1.6

19.3

563

3901

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

19.3

165

776

H02AB09

ATC

hydrocortisone; systemic

3.9

19.3

150

212

Kela drug reimbursment

Gout

3.5

19.2

202

M54.5

ICD-10 Finland

Low back pain

1.6

19.2

670

4841

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

19.2

303

1772

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

16.9

19.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

19.0

260

1452

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.9

19.0

147

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

18.9

124

519

M79.6

ICD-10 Finland

Pain in limb

1.5

18.9

839

6399

I50.0

ICD-10 Finland

Congestive heart failure

1.9

18.8

246

1354

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

18.8

L01BC06

ATC

capecitabine; oral

+∞

18.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

18.8

WW409

NOMESCO Finland

Other aferesis

+∞

18.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

18.7

823

6258

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

101.0

18.6

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

38.8

18.6

L04AX02

ATC

thalidomide; oral

191.8

18.6

B74

ICPC

Malignant neoplasm blood other

191.8

18.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

18.5

147

670

TGC00

NOMESCO Finland

Bronchial lavation

3.4

18.4

208

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

18.3

196

1005

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

44.4

18.2

A46

ICD-10 Finland

Erysipelas

1.7

18.1

350

2172

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

18.0

176

872

306

Kela drug reimbursment

Erythropoietin and darbepoetin

33.2

18.0

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.4

17.9

105

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

7.7

17.8

XW000, ,

SPAT

67.2

17.7

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

17.7

C90

ICD-10 Finland

Multiple myeloma and malignant plasma cell neoplasms

+∞

17.7

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

17.7

S97

ICPC

Chronic ulcer skin

2.1

17.6

179

900

ZX070

NOMESCO Finland

Intensity modified radiotherapy

95.9

17.6

R31

ICD-10 Finland

Unspecified haematuria

1.9

17.5

234

1296

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

17.5

823

6321

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.5

393

2540

G04BE03

ATC

sildenafil; oral

7.8

17.4

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

7.1

17.4

D07AC01

ATC

betamethasone; topical

1.5

17.2

704

5244

L04AA01

ATC

[U] ciclosporin

4.8

17.1

Z94.0

ICD-10 Finland

Kidney transplant status

6.7

17.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

17.0

622

4520

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.7

16.9

334

R5110, ,

SPAT

1.9

16.9

213

1157

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

16.8

225

N02BF02

ATC

pregabalin; oral

2.2

16.8

143

670

TAB00

NOMESCO Finland

Lumbar puncture

2.7

16.8

352

3060, ,

Kela drug reimbursment

+∞

16.7

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

16.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

16.7

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

16.7

1534, ,

Kela drug reimbursment

+∞

16.7

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

16.7

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

16.7

ZXC20

NOMESCO Finland

Use of chemical agents

4.4

16.7

L04AX01

ATC

azathioprine; systemic

2.7

16.6

337

M05BA02

ATC

clodronic acid; systemic

171.4

16.5

R51.80

ICD-10 Finland

Headache

1.8

16.4

266

1566

N05CF01

ATC

zopiclone; oral

1.5

16.3

628

4607

SPAT1255

SPAT

Intravenous administration of medicine

2.1

16.2

154

754

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

16.2

192

1021

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

16.2

350

2235

A08

ICPC

Swelling

2.2

16.1

143

682

137

Kela drug reimbursment

Uraemia requiring dialysis

6.0

16.1

A03

ICPC

Fever

1.8

16.0

252

1470

A04

ICPC

Weakness/tiredness general

1.7

16.0

326

2049

J01FA06

ATC

roxithromycin; oral

1.5

15.9

724

5493

L02AE04

ATC

triptorelin; parenteral

+∞

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

15.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

15.6

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

15.6

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

15.6

L02BG03

ATC

anastrozole; oral

+∞

15.6

WW402

NOMESCO Finland

Leucoferesis

+∞

15.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.6

C421, 9761, 1

ICD-O-3

+∞

15.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

15.6

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

15.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

15.6

373

2441

N02BF01

ATC

gabapentin; oral

1.9

15.6

221

1247

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

5.6

15.6

XQ848

NOMESCO Finland

Dermatological photography

3.2

15.6

199

ZXC50

NOMESCO Finland

Cryotherapy

3.2

15.6

199

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

4.0

15.4

113

R60.0

ICD-10 Finland

Localized oedema

1.7

15.4

290

1782

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

15.3

268

1613

WX892

NOMESCO Finland

Monitored bed care

2.0

15.2

168

870

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

15.2

112

494

R06AE07

ATC

cetirizine; oral

1.5

15.1

705

5363

GA5AA

NOMESCO Finland

Rib X-ray examination

14.1

15.0

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

15.0

114

510

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.9

15.0

111

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

15.0

120

549

G04CA02

ATC

tamsulosin; oral

1.5

14.9

571

4168

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

14.8

347

2259

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.8

14.7

N18.0

ICD-10 Finland

End-stage renal disease

4.7

14.7

C08CA05

ATC

nifedipine; systemic

2.0

14.6

154

784

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.5

14.6

141

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

14.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

14.6

L01XG03

ATC

ixazomib; oral

+∞

14.6

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

14.6

NB4AA

NOMESCO Finland

Scapula X-ray examination

12.0

14.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

14.3

14.5

SPAT1254

SPAT

Administration of medicine

1.7

14.5

312

1984

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.6

14.5

132

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

151.1

14.5

J01FA10

ATC

azithromycin; systemic

1.5

14.4

881

7044

DHB00

NOMESCO Finland

Excision of lesion of external nose

15.5

14.4

SPAT1263

SPAT

Sampling

1.5

14.4

777

6067

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

14.4

269

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

14.4

273

1679

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

14.4

375

R03AC02

ATC

salbutamol; inhalant

1.4

14.2

965

7861

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

22.4

14.2

ZXA10

NOMESCO Finland

Bilateral

1.6

14.1

387

2614

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

14.1

102

446

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

42.8

14.1

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

14.0

156

810

L17

ICPC

Foot/toe symptom/complaint

1.5

13.9

608

4547

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.7

13.9

297

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

30.3

13.9

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

5.1

13.8

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

13.8

210

1209

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

17.7

13.8

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.8

13.8

113

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

23.9

13.8

V03AE01

ATC

polystyrene sulfonate; oral

4.0

13.7

100

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.8

13.7

248

ZXC15

NOMESCO Finland

Use of photodynamic technique

5.2

13.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

13.6

271

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

13.6

372

B01AB04

ATC

dalteparin; parenteral

2.4

13.6

416

L01XX35

ATC

anagrelide; oral

+∞

13.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

13.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

13.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

13.6

L01XX50

ATC

[U] ixazomib

+∞

13.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

13.5

215

1255

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

140.9

13.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.5

353

2358

A07AA09

ATC

vancomycin; oral

3.8

13.4

106

S29

ICPC

Skin symptom/complaint other

1.6

13.4

382

2602

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

13.4

104

470

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

13.4

526

3845

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

13.3

369

2496

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

13.3

377

2563

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.5

13.3

R11

ICD-10 Finland

Nausea and vomiting

1.9

13.3

161

861

SPAT1229

SPAT

Assessment of need for aid

1.9

13.3

185

1036

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

13.3

184

1029

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

13.3

348

2323

SPAT1153

SPAT

Removal of sutures

1.5

13.2

580

4331

A79

ICPC

Malignancy NOS

40.4

13.2

R02

ICPC

Shortness of breath/dyspnoea

1.6

13.2

302

1951

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.6

13.1

288

WX320

NOMESCO Finland

Spinalanesthesy

1.5

13.1

491

3552

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

13.0

431

J01AA02

ATC

doxycycline; systemic

1.5

12.9

1438

12738

A02BC05

ATC

esomeprazole; systemic

1.4

12.9

740

5811

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

12.9

122

597

K92.1

ICD-10 Finland

Melaena

2.1

12.9

130

652

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

12.9

125

618

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.7

12.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.5

12.8

124

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.4

12.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

12.8

849

6845

XX2RW, ,

NOMESCO Finland

5.8

12.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

12.7

676

5232

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.7

12.7

258

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.1

12.7

170

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

12.6

219

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.5

12.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

70.3

12.6

A07AA02

ATC

nystatin; oral

2.1

12.6

124

616

ZY010

NOMESCO Finland

Hospital outpatient

2.6

12.6

277

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

12.6

122

603

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

12.5

431

A98

ICPC

Health maint/preventive medicine

1.8

12.5

1793

16746

M25.5

ICD-10 Finland

Pain in joint

1.5

12.5

562

4209

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

12.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

12.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

12.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

12.5

2731A

ICD-9 Finland

Disorders of plasma protein metabolism, Monoclonal paraproteinaemia

+∞

12.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

12.5

N06AX11

ATC

mirtazapine; oral

1.5

12.5

617

4706

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

12.4

320

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

130.8

12.4

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

12.4

117

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

12.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

12.3

253

1588

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.8

12.3

L04AD02

ATC

tacrolimus; systemic

5.8

12.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

37.8

12.2

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.1

12.2

164

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

12.1

108

516

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

6.1

12.1

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

6.1

12.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

12.1

563

4240

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

12.1

119

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

12.1

362

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

12.1

150

810

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

12.0

142

754

L03

ICPC

Low back symptom/complaint

1.5

12.0

518

3845

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.3

12.0

XF402

NOMESCO Finland

ECG with work load test

1.7

11.9

238

1481

ZX100

NOMESCO Finland

Oral

3.9

11.8

R04.0

ICD-10 Finland

Epistaxis

1.8

11.8

177

1014

207

Kela drug reimbursment

Chronic arrhythmias

1.5

11.8

414

2946

Z49.2

ICD-10 Finland

Other dialysis

5.2

11.7

PJA10

NOMESCO Finland

Exploration of lymph nodes

9.7

11.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

11.7

594

4542

J94.8

ICD-10 Finland

Other specified pleural conditions

3.5

11.7

112

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

11.7

121

613

B01AF02

ATC

apixaban; oral

1.6

11.6

344

2356

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

11.6

1353

11940

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

11.6

574

4366

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.8

11.6

SPAT1211

SPAT

Application of soft bandage

1.8

11.6

167

946

3025

Kela drug reimbursment

Calcium carbonate

5.3

11.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

11.5

219

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

11.5

208

SPAT1088

SPAT

Blood transfusion

10.1

11.5

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

11.5

179

1038

M79.1

ICD-10 Finland

Myalgia

1.7

11.5

251

1599

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

11.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

11.5

1512

Kela drug reimbursment

Ibrutinib

+∞

11.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

11.5

390

Kela drug reimbursment

Ibrutinib

+∞

11.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

9731/3-C42.1

ICD-O-3

Plasmacytoma, NOS, of bone marrow

+∞

11.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

11.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

11.5

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

11.5

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

11.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

11.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

11.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

11.5

296

SPAT1262

SPAT

Handing over of treatment supplies

1.5

11.5

366

2550

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

120.7

11.4

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

11.4

289

1909

D07AB08

ATC

desonide; topical

1.8

11.3

193

1149

1XC02, ,

NOMESCO Finland

8.9

11.3

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.4

11.2

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

11.2

128

671

N17.8

ICD-10 Finland

Other acute renal failure

3.6

11.2

101

B99

ICPC

Blood/lymph/spleen disease other

12.8

11.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

11.1

121

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.1

307

2070

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

11.1

512

3840

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

8.1

11.1

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.8

11.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.0

11.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

11.0

352

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

11.0

124

648

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

11.0

805

6549

A99

ICPC

Disease/condition unspecnature/site

1.7

10.9

213

1316

SPAT1260

SPAT

Consultation of another employee

1.5

10.9

335

2311

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

10.9

510

3834

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

10.9

317

2163

NF3AA

NOMESCO Finland

Femur X-ray examination

2.7

10.8

209

Z01.2

ICD-10 Finland

Dental examination

1.4

10.8

724

5795

ZQZ00

NOMESCO Finland

Treatment of several skin areas

15.6

10.8

Z2446

NOMESCO Finland

Social worker

2.1

10.8

102

499

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.8

334

2308

B02.9

ICD-10 Finland

Zoster without complication

1.8

10.8

151

847

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

10.8

159

907

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

10.7

580

4476

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

21.6

10.7

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

10.6

276

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

60.3

10.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

60.3

10.6

D47.7

ICD-10 Finland

Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

60.3

10.6

L88

ICPC

Rheumatoid/seropositive arthritis

2.2

10.6

409

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

10.6

117

607

L04AA13

ATC

[U] leflunomide

2.7

10.5

207

J12.8

ICD-10 Finland

Other viral pneumonia

4.7

10.5

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

10.5

893

7426

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

10.5

366

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

10.4

111

568

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

110.6

10.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

10.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

10.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

10.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

10.4

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

A04AD12

ATC

aprepitant; systemic

+∞

10.4

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

10.4

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

+∞

10.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

10.3

106

535

R4180

NOMESCO Finland

Podiatric therapy

3.5

10.3

102

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

10.3

170

1003

V03AE03

ATC

lanthanum carbonate; oral

10.6

10.3

D11

ICPC

Diarrhoea

1.7

10.2

182

1096

R4120

NOMESCO Finland

Occupational therapy

1.9

10.2

124

664

R42

ICD-10 Finland

Dizziness and giddiness

1.4

10.2

481

3614

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

10.2

101

504

J01FA09

ATC

clarithromycin; systemic

1.4

10.2

488

3679

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.1

431

3176

H05BX01

ATC

cinacalcet; oral

5.3

10.1

UJF92

NOMESCO Finland

Capsular endoscopy

2.9

10.1

155

ZXA00

NOMESCO Finland

Right side

1.4

10.1

491

3709

EBA10

NOMESCO Finland

Operative extraction of tooth

1.8

10.0

153

882

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

10.0

373

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.1

10.0

WPA13

NOMESCO Finland

Palliative consultation

10.1

10.0

G61.8

ICD-10 Finland

Other inflammatory polyneuropathies

14.6

10.0

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

10.0

248

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

9.9

5BA08, ,

NOMESCO Finland

7.7

9.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

9.9

161

946

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

9.8

111

580

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.8

192

1188

C10AC01

ATC

colestyramine; oral

2.6

9.8

209

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

9.6

9.8

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.2

9.7

116

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.9

9.7

153

R01AD09

ATC

mometasone; nasal

1.4

9.7

694

5590

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

7.4

9.7

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.3

9.7

301

B01AA03

ATC

warfarin; systemic

1.4

9.7

469

3537

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

13.4

9.7

3XA02, ,

NOMESCO Finland

55.3

9.6

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.8

9.6

B02AA02

ATC

tranexamic acid; systemic

1.7

9.5

186

1149

D06BB10

ATC

imiquimod; topical

2.1

9.5

414

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.8

9.5

166

TPH00

NOMESCO Finland

Phlebotomy

15.1

9.5

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

15.1

9.5

N06AA09

ATC

amitriptyline; systemic

1.7

9.5

190

1182

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

9.4

204

1294

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

100.5

9.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

100.5

9.4

GDC00

NOMESCO Finland

Lobectomy of lung

100.5

9.4

R52.9

ICD-10 Finland

Pain, unspecified

1.7

9.4

194

1216

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

9.4

219

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

30.2

9.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

9.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

9.4

L01EL01

ATC

ibrutinib; oral

+∞

9.4

Z52.89

ICD-10 Finland

Donor of other organ or tissue

+∞

9.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

9.4

YX9AW, ,

NOMESCO Finland

+∞

9.4

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

9.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

9.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

9.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

9.4

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

+∞

9.4

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

+∞

9.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

9.4

262

U71

ICPC

Cystitis/urinary infection other

1.9

9.3

122

670

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

8.1

9.3

C09CA06

ATC

candesartan; oral

1.4

9.3

447

3361

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

9.3

170

1031

M01AH05

ATC

etoricoxib; oral

1.3

9.3

1034

8893

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.3

557

4352

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.5

9.3

-54

ICPC

Repair/fix-suture/cast/prosth device

2.8

9.3

157

ZZA00

NOMESCO Finland

Split skin graft

2.7

9.3

191

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

9.3

197

S21

ICPC

Skin texture symptom/complaint

1.5

9.3

275

1880

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

9.6

9.3

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.9

9.3

141

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

9.3

209

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.9

9.2

152

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

9.2

340

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

9.2

342

2450

D07AC13

ATC

mometasone; topical

1.4

9.2

500

3844

WX722

NOMESCO Finland

PEEP

2.0

9.1

491

A02BC03

ATC

lansoprazole; oral

1.4

9.1

541

4223

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

9.1

147

863

NG1DA

NOMESCO Finland

X-ray of knees

2.8

9.0

154

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.1

9.0

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.1

9.0

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

10.1

9.0

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

9.0

230

L01BA01

ATC

methotrexate; systemic

2.2

9.0

344

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.6

9.0

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

9.0

299

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

8.9

162

981

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

8.9

249

A97

ICPC

No disease

1.5

8.9

368

2689

WF099

NOMESCO Finland

Other radiotherapy

18.7

8.9

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

8.9

221

1450

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

24.1

8.9

R05

ICPC

Cough

1.4

8.9

441

3334

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

8.9

326

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.4

8.9

244

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

8.9

307

Z71.8

ICD-10 Finland

Other specified counselling

1.4

8.8

546

4283

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.8

1038

8974

R55

ICD-10 Finland

Syncope and collapse

1.5

8.8

249

1684

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.7

8.8

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.5

8.8

K08.3

ICD-10 Finland

Retained dental root

1.7

8.8

158

956

SPAT1336

SPAT

Request for examination

2.1

8.7

361

U04

ICPC

Incontinence urine

1.8

8.7

132

759

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

8.7

116

641

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.9

8.7

135

X76

ICPC

Malignant neoplasm breast female

50.2

8.7

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

50.2

8.7

TKC22

NOMESCO Finland

Catheterisation instruction

2.6

8.7

198

M03BX02

ATC

tizanidine; oral

1.3

8.7

990

8514

SPAT1301

SPAT

No procedures

1.4

8.7

594

4736

C09AA05

ATC

ramipril; oral

1.4

8.6

568

4498

M48.0

ICD-10 Finland

Spinal stenosis

1.5

8.6

280

1950

A10BH05

ATC

linagliptin; oral

1.8

8.6

128

732

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

8.6

123

695

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.6

131

755

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.2

8.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

8.6

L02AE03

ATC

goserelin; implant

16.4

8.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.0

8.5

R33

ICD-10 Finland

Retention of urine

1.6

8.5

182

1151

B80

ICPC

Iron deficiency anaemia

2.5

8.5

218

R74

ICPC

Upper respiratory infection acute

1.4

8.5

398

2976

WW400

NOMESCO Finland

Plasmaferesis

27.6

8.5

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

20.1

8.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.1

8.4

116

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

8.4

256

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

8.4

201

Z51.0

ICD-10 Finland

Radiotherapy session

90.4

8.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

90.4

8.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

8.4

377

2797

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

8.4

103

555

A10AB05

ATC

insulin aspart; parenteral

1.7

8.4

152

921

XG405

NOMESCO Finland

Education on PEF monitoring

3.2

8.4

101

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.9

8.4

J20

ICD-10 Finland

Acute bronchitis

1.7

8.3

172

1078

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

8.3

174

Kela drug reimbursment

Ruxolitinib

+∞

8.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

8.3

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

8.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

8.3

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

8.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

8.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

8.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

8.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

8.3

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

+∞

8.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

8.3

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.3

8.3

264

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

8.3

121

689

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

8.2

WPB10

NOMESCO Finland

Making a convalescent care decision

14.5

8.2

R01AD08

ATC

fluticasone; nasal

1.4

8.2

429

3268

R03DC03

ATC

montelukast; oral

1.5

8.2

261

1812

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.6

8.1

B05DA

ATC

Isotonic solutions

4.6

8.1

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.6

8.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.2

8.1

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.4

8.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

8.1

158

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

11.7

8.1

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

8.0

170

E000001, ,

ATC

1.5

8.0

313

2260

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.1

8.0

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.7

8.0

Z31.5

ICD-10 Finland

Genetic counselling

2.5

8.0

194

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

8.0

171

1082

G47.3

ICD-10 Finland

Sleep apnoea

1.4

8.0

405

3067

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.9

8.0

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

8.0

143

864

XF602

NOMESCO Finland

Bloodpressure monitoring

3.5

8.0

K86.2

ICD-10 Finland

Cyst of pancreas

3.5

8.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

7.9

328

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

7.9

430

J01DA06

ATC

[U] cefuroxime

1.5

7.9

230

1563

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

7.9

101

551

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

7.9

189

WX882

NOMESCO Finland

High dependency care

2.4

7.9

232

R35

ICD-10 Finland

Polyuria

1.7

7.9

151

928

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.7

7.9

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.5

7.9

B05DB

ATC

Hypertonic solutions

4.6

7.9

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

13.1

7.9

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

7.9

130

768

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

7.8

284

M10.9

ICD-10 Finland

Gout, unspecified

1.6

7.8

169

1072

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

7.8

252

SPAT1127

SPAT

Enema

3.8

7.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

7.8

135

808

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

9.4

7.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

7.8

196

1291

U14

ICPC

Kidney symptom/complaint

2.7

7.8

150

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.7

7.7

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

7.7

118

681

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

7.7

386

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

7.7

376

2826

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

45.2

7.7

C50

ICD-10 Finland

Malignant neoplasm of breast

45.2

7.7

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

7.7

666

5477

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.8

7.7

128

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.0

7.7

112

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

3.3

7.7

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.1

7.7

313

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.5

7.6

P01AB01

ATC

metronidazole; oral, rectal

1.3

7.6

635

5192

XQ800

NOMESCO Finland

Prick test

1.9

7.6

493

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

7.6

109

617

K03.66

ICD-10 Finland

Tooth plaque

1.7

7.6

136

821

XG466

NOMESCO Finland

Sleep oxymetry

2.2

7.6

281

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

7.6

156

977

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

18.4

7.6

A01

ICPC

Pain general/multiple sites

1.6

7.6

194

1282

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

25.1

7.6

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

7.6

466

E87.5

ICD-10 Finland

Hyperkalaemia

2.4

7.6

212

C08CA02

ATC

felodipine; oral

1.5

7.5

221

1505

RD210, ,

NOMESCO Finland

3.2

7.5

N63

ICD-10 Finland

Unspecified lump in breast

2.1

7.5

342

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

7.5

302

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

7.5

270

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

7.5

446

3466

ED1AA

NOMESCO Finland

Mandibular X-ray examination

7.1

7.5

ZX114

NOMESCO Finland

Intramuscular

3.7

7.5

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

7.5

433

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.8

7.4

125

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

80.4

7.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

80.4

7.4

D89.2

ICD-10 Finland

Hypergammaglobulinaemia, unspecified

80.4

7.4

ZXC96

NOMESCO Finland

Robot assisted procedure

6.5

7.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.5

7.4

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

13.4

7.4

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.0

7.4

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

6.0

7.4

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.3

135

822

N03AX09

ATC

lamotrigine; oral

2.2

7.3

253

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

7.3

237

1649

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

C90.1

ICD-10 Finland

Plasma cell leukaemia

+∞

7.3

L02BB04

ATC

enzalutamide; oral

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

D47.0

ICD-10 Finland

Histiocytic and mast cell tumours of uncertain and unknown behaviour

+∞

7.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

7.3

NB4DA

NOMESCO Finland

Bilateral scapula X-ray examination

+∞

7.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

7.3

WD335, ,

NOMESCO Finland

+∞

7.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

7.3

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

7.3

L01CB01

ATC

etoposide; systemic

+∞

7.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

7.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

7.3

197

R06AX27

ATC

desloratadine; oral

1.4

7.3

379

2879

R81

ICPC

Pneumonia

2.0

7.3

402

SPAT1325

SPAT

Vaccination

1.3

7.2

653

5392

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

7.2

127

M45

ICD-10 Finland

Ankylosing spondylitis

2.8

7.2

127

6BA02, ,

NOMESCO Finland

15.8

7.2

S77

ICPC

Malignant neoplasm of skin

15.8

7.2

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.3

7.2

N06AX16

ATC

venlafaxine; oral

1.6

7.2

182

1199

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.0

7.2

100

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.3

7.2

J01DA01

ATC

[U] cefalexin

1.3

7.2

1058

9321

TK810

NOMESCO Finland

Hemofiltration

4.5

7.2

J01FA15

ATC

telithromycin; oral

1.6

7.2

148

929

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.2

214

1464

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

20.1

7.1

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

20.1

7.1

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

20.1

7.1

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.3

7.1

A05AA02

ATC

ursodeoxycholic acid; oral

3.4

7.1

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

7.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.1

669

5557

M02AA07

ATC

piroxicam; topical

1.3

7.1

668

5549

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.4

7.0

188

ELB10

NOMESCO Finland

Excision of minor salivary gland

10.1

7.0

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

7.0

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.4

7.0

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

4.4

7.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

7.0

120

718

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.9

437

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

6.9

107

620

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.3

6.9

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.7

6.9

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

6.9

510

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.0

6.9

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

6.9

389

2993

L95

ICPC

Osteoporosis

1.9

6.9

460

M81.5

ICD-10 Finland

Idiopathic osteoporosis

3.6

6.9

SPAT1216

SPAT

Assessment of functional ability

1.4

6.9

337

2533

SPAT1125

SPAT

Stoma care and guidance

2.8

6.9

114

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

6.8

141

885

XX9XE

NOMESCO Finland

Other ultrasound examination

4.1

6.8

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

6.8

119

715

R07.3

ICD-10 Finland

Other chest pain

1.5

6.8

195

1323

A07EA06

ATC

budesonide; oral, local oral

2.1

6.8

295

N03.5

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis

40.2

6.8

J02AC03

ATC

voriconazole; systemic

16.7

6.7

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

6.7

192

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

6.7

192

1300

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.2

6.7

230

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.3

6.7

211

RS221, ,

NOMESCO Finland

3.2

6.7

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

7.2

6.7

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.3

6.7

M01AB05

ATC

diclofenac; systemic, rectal

1.3

6.7

1111

9898

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

6.7

103

597

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

22.6

6.7

WX212

NOMESCO Finland

Femoral plexus blockade

2.2

6.6

264

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

6.6

255

1834

B07.9

ICD-10 Finland

Verruca simplex

2.3

6.6

225

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

6.4

6.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.6

710

5984

R60.1

ICD-10 Finland

Generalized oedema

4.0

6.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

6.6

151

972

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.9

6.6

M01AH01

ATC

celecoxib; oral

1.4

6.6

318

2383

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

6.6

570

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

12.3

6.6

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.2

6.6

TEA00

NOMESCO Finland

Biopsy of lip

3.4

6.6

L04AA32

ATC

apremilast; oral

10.1

6.5

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

6.5

320

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

6.5

127

786

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

6.5

557

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

6.5

169

1122

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

6.5

215

1503

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

6.5

321

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

6.5

412

3228

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

6.5

132

827

R19.5

ICD-10 Finland

Other faecal abnormalities

2.5

6.4

153

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.9

6.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

70.1

6.4

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

70.1

6.4

DAB10

NOMESCO Finland

Partial excision of auricle

70.1

6.4

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

70.1

6.4

D89.1

ICD-10 Finland

Cryoglobulinaemia

70.1

6.4

L02BG06

ATC

exemestane; oral

70.1

6.4

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

6.4

138

876

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

14.3

6.4

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.1

6.4

275

A60

ICPC

General and Unspecified, Result test/procedure

1.9

6.4

421

C08CA13

ATC

lercanidipine; oral

1.4

6.4

307

2299

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.4

290

2151

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.1

6.4

V03AE02

ATC

sevelamer; oral

6.6

6.3

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

6.3

111

668

R04.2

ICD-10 Finland

Haemoptysis

1.9

6.3

387

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.6

6.3

131

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

6.3

380

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

6.3

161

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.5

6.3

N06.9

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, unspecified

9.3

6.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.3

415

3268

C02AC05

ATC

moxonidine; oral

1.7

6.3

100

586

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

6.3

374

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.3

204

1421

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

6.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

6.3

374

Kela drug reimbursment

Ruxolitinib

+∞

6.3

L03AB04

ATC

interferon alfa-2a; parenteral

+∞

6.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.3

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

6.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

6.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.3

L01EJ01

ATC

ruxolitinib; oral

+∞

6.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

6.3

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

6.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

6.3

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

+∞

6.3

N16.1*C90.0

ICD-10 Finland

Renal tubulo-interstitial disorders in multiple myeloma

+∞

6.3

L02BX02

ATC

degarelix; parenteral

+∞

6.3

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

6.3

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

6.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.3

J01EA01

ATC

trimethoprim; systemic

1.3

6.2

407

3199

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

26.8

6.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

6.2

298

2229

A41.8

ICD-10 Finland

Other specified sepsis

2.3

6.2

193

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.7

6.2

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

6.2

319

2415

N05BA04

ATC

oxazepam; oral

1.3

6.2

443

3529

L13

ICPC

Hip symptom/complaint

1.4

6.2

377

2933

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.9

6.2

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.3

6.2

H26.3

ICD-10 Finland

Drug-induced cataract

5.3

6.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

6.1

163

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

6.1

674

5686

I73.0

ICD-10 Finland

Raynaud syndrome

2.8

6.1

110

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.1

890

7772

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.9

6.1

385

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

6.1

322

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

6.1

336

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

8.6

6.1

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

6.1

WX704

NOMESCO Finland

Intubation

1.7

6.0

118

731

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.5

6.0

140

JFF23

NOMESCO Finland

Transversostomy

6.7

6.0

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

6.0

111

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

6.0

268

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.2

6.0

R2110

NOMESCO Finland

Giving the first information

1.8

6.0

548

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.5

6.0

L99

ICPC

Musculoskeletal disease other

2.3

6.0

196

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

6.0

384

3007

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.3

6.0

K29.6

ICD-10 Finland

Other gastritis

2.8

6.0

100

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

6.0

120

748

RS220, ,

NOMESCO Finland

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017704) Immunofixation for Urine

226

26.48

320.64

1.9

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1651

7699

8.24

319.53

12.4

3.9

35.13

35.21

g/l

0.22

1577

7109

(3023520) Reticulocytes [#/volume] in Blood

900

1786

8.47

307.65

3.7

2.0

65.56

67.53

e9/l

0.79

676

1315

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1263

545

63.30

307.65

7.6

1.3

6.84

1.42

ratio

2.72

813

320

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1096

795

29.99

307.65

7.5

1.3

3.87

3.73

g/l

0.71

1034

705

(3007164) IgA [Mass/volume] in Serum or Plasma

1120

2774

8.08

307.65

4.6

1.3

3.40

2.74

g/l

4.46

941

1532

(3045142) Bone marrow Pathology biopsy report

296

46.93

307.65

1.3

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1003

830

23.69

307.65

5.1

1.3

3.23

1.14

g/l

20.29

902

761

(3042111) Morphology [Interpretation] in Bone marrow Narrative

607

150

58.16

307.65

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

419

88.54

307.65

1.9

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1335

610

66.42

307.65

8.2

1.3

55.66

34.69

mg/l

4.26

1161

514

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

790

577

22.25

307.65

8.0

1.3

0.18

0.00

g/l

6.93

672

522

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

742

554

20.94

307.65

8.0

1.3

0.01

0.00

g/l

1.93

597

491

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

616

524

16.68

307.65

9.2

1.3

0.00

g/l

-0.00

596

489

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1090

670

35.38

307.65

7.9

1.3

5.09

0.10

g/l

96.42

871

575

(21494890) Protein electrophoresis panel - 24 hour Urine

667

155

64.70

307.65

2.9

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

921

705

23.75

307.65

7.7

1.3

11.84

10.29

g/l

8.39

838

611

(21494434) Karyotype in Bone marrow

237

32.74

307.65

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1079

1047

21.69

307.65

6.3

2.2

12.62

10.83

g/l

10.74

1008

960

(3020876) Protein [Mass/time] in 24 hour Urine

507

196

34.54

307.65

2.8

1.9

0.76

1.64

g/24h

1.74

351

104

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1096

797

29.91

307.65

7.5

1.2

4.35

4.20

g/l

1.96

1034

708

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1142

1773

14.03

307.65

6.3

2.0

226.42

233.22

u/l

1.23

1098

1645

(3034860) Kappa light chains.free [Mass/volume] in Serum

1336

612

66.36

307.65

8.2

1.3

68.40

43.39

mg/l

7.08

1156

517

(3037756) Immunofixation for Serum or Plasma

1201

327

93.19

307.65

2.2

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1097

798

29.93

307.65

7.5

1.2

6.92

7.53

g/l

15.11

1033

706

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1039

737

28.86

307.65

7.7

1.3

2.60

2.95

g/l

14.03

977

647

(3027945) Reticulocytes/Erythrocytes in Blood

1048

2293

8.67

307.65

3.7

2.0

1.73

1.77

0.77

977

2009

(3020630) Protein [Mass/volume] in Serum or Plasma

1571

1564

46.48

307.65

9.6

1.4

69.27

66.34

g/l

27.87

1500

1408

(3001604) Monocytes [#/volume] in Blood

1687

8193

8.58

306.61

13.5

5.4

0.60

0.62

e9/l

1.16

1537

6895

(42870588) Differential panel, method unspecified - Blood

1358

5482

5.80

306.11

11.8

5.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

153

138.20

305.06

3.1

1.3

—

(3019069) Monocytes/Leukocytes in Blood

1607

7503

7.33

304.12

13.9

5.7

9.47

9.13

3.87

1553

6928

(3006315) Basophils [#/volume] in Blood

1687

8234

8.51

303.54

13.5

5.4

0.04

e9/l

0.10

1535

6931

(3006504) Eosinophils/Leukocytes in Blood

1602

7491

7.22

301.59

13.6

5.6

2.87

2.99

1.19

1549

6925

(3019198) Lymphocytes [#/volume] in Blood

1692

8352

8.48

298.29

13.7

5.5

1.83

1.80

e9/l

0.27

1562

7202

(3003458) Phosphate [Moles/volume] in Serum or Plasma

837

2319

5.55

296.23

9.2

5.3

1.07

1.03

mmol/l

3.41

791

2131

(3002030) Lymphocytes/Leukocytes in Blood

1605

7604

7.12

294.79

13.7

5.7

27.88

26.37

5.42

1562

7116

(3022096) Basophils/Leukocytes in Blood

1592

7503

6.96

293.74

13.9

5.7

0.70

0.67

1.35

1540

6928

(3018010) Neutrophils/Leukocytes in Blood

1588

7491

6.89

291.93

13.2

5.6

56.43

58.43

8.11

1546

7071

(3013115) Eosinophils [#/volume] in Blood

1694

8495

8.30

289.34

14.2

5.5

0.19

0.21

e9/l

5.09

1558

7268

(3018418) pH of Serum or Plasma

1302

5283

5.36

285.39

12.4

3.4

7.39

7.40

1.47

1059

3825

(3013650) Neutrophils [#/volume] in Blood by Automated count

1712

8751

8.53

283.56

20.9

6.1

3.94

4.39

e9/l

13.57

1567

7416

(4035726) Immunohistochemistry procedure

349

434

9.57

269.43

1.5

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1719

9064

8.26

267.17

18.6

6.1

1.22

1.21

mmol/l

1.69

1555

7756

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

484

905

6.77

259.64

2.1

1.6

1.43

1.53

g/l

1.36

413

788

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

131

127.54

259.19

3.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1165

4630

4.74

253.73

5.2

2.6

355.78

361.83

umol/l

1.00

1076

3937

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1592

8083

6.15

251.24

15.5

5.7

1.22

1.21

mmol/l

6.86

1542

7297

(3036603) Volume of Urine

192

100

21.18

249.83

2.0

1.6

1904.61

1906.11

0.01

192

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

847

2677

4.81

248.32

4.4

2.7

22.53

22.01

0.52

819

2457

(3004789) Transferrin [Mass/volume] in Serum or Plasma

885

2902

4.74

247.23

4.3

2.6

2.17

2.27

g/l

5.82

849

2646

(3022948) Iron [Moles/volume] in Serum or Plasma

917

3114

4.65

244.15

4.3

2.7

12.02

12.43

umol/l

1.05

884

2861

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

304

385

9.16

230.15

1.7

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

537

1289

5.36

217.39

1.8

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1557

8364

5.18

211.71

10.7

3.9

11.25

12.34

umol/l

2.13

1517

7852

(46235355) HIV 1 and 2 tests - Meaningful Use set

571

1498

4.97

207.00

1.9

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

494

1185

5.24

198.75

1.7

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

374

703

6.34

196.60

1.4

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

187

295.44

186.37

1.2

1.0

—

(3000012) Reticulocyte production index

224

267

9.34

176.74

2.7

1.6

0.90

0.89

0.08

185

176

(3015377) Calcium [Moles/volume] in Serum or Plasma

1180

5709

3.68

173.05

5.0

2.2

2.34

2.35

mmol/l

3.06

1080

4974

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1058

4847

3.57

167.64

3.2

2.4

2.89

2.83

mg/l

0.35

943

4139

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

130

20.11

166.95

3.5

1.1

41.53

38.90

g/l

2.65

130

(3044927) Protein electrophoresis panel - Urine

207

240

9.52

166.67

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

646

2185

3.92

162.48

1.5

1.3

537.02

550.49

titre

0.06

141

534

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1337

7248

3.65

158.71

5.3

3.0

181.71

136.85

ug/l

5.91

1266

6634

(3023368) Bacteria identified in Blood by Culture

1067

5054

3.44

157.44

6.9

4.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

723

2729

3.61

152.87

4.3

2.4

0.80

0.82

mmol/l

5.90

675

2517

(3017181) Myelocytes/Leukocytes in Blood

481

1395

4.24

148.89

7.3

3.8

0.76

0.77

0.02

221

292

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

64.95

146.86

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

185

223

9.06

144.14

5.5

5.4

19981.59

530.29

iu/ml

0.48

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

250

428

6.55

142.72

3.9

2.5

1.87

1.78

mg/l

0.58

231

368

(3002179) Metamyelocytes/Leukocytes in Blood

458

1341

4.15

139.19

7.1

3.6

0.63

0.62

0.02

211

290

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

479

1475

3.97

135.34

5.7

3.7

104.79

93.86

ng/l

1.53

414

1245

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

200

287

7.65

134.50

1.4

1.2

45.31

19.37

u/l

5.11

194

243

(40760892) CBC W Ordered Manual Differential panel - Blood

764

3218

3.25

131.94

10.4

4.3

—

(3021440) Promyelocytes/Leukocytes in Blood

449

1360

3.98

129.40

7.5

3.8

0.13

0.07

0.97

190

257

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

248

463

5.99

129.27

2.0

1.7

0.22

0.23

g/l

0.96

237

438

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

250

471

5.94

129.07

1.9

1.6

1.18

1.17

g/l

0.14

241

443

(3037121) Protein [Mass/volume] in Urine

276

576

5.41

127.41

2.1

2.6

797.41

302.46

mg/l

0.49

150

203

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

756

3272

3.13

123.04

2.6

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

500

1682

3.65

122.96

10.8

6.6

12.59

11.40

mmol/l

2.49

481

1593

(3021589) Normoblasts [#/volume] in Blood

1240

7058

3.06

122.59

25.7

10.8

0.01

0.00

e9/l

1.11

1053

5711

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1773

12608

5.24

120.06

18.3

5.7

82.79

77.97

u/l

3.03

1744

11710

(3018677) aPTT in Platelet poor plasma by Coagulation assay

677

2787

3.18

119.61

3.1

1.9

29.90

29.80

0.15

656

2705

(3025159) Blasts/Leukocytes in Blood

439

1389

3.78

117.92

7.9

4.0

0.82

0.01

0.88

177

244

(3009445) Proteinase 3 Ab [Units/volume] in Serum

320

808

4.54

117.15

1.2

1.6

1.72

24.57

iu/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1083

5859

2.89

115.18

2.4

1.7

20.74

20.04

nmol/l

0.73

974

4849

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

161

9.29

112.77

2.3

2.4

219.75

251.50

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

117

138.15

110.37

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

1041

5756

2.72

102.23

5.2

3.3

29.10

78.52

e6/l

3.04

853

4384

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

572

2313

3.08

101.96

2.4

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

936

4922

2.73

101.41

5.1

3.2

0.49

0.52

e6/l

0.14

750

3613

(3018095) Leukocytes [#/volume] in Urine

1115

6431

2.70

99.76

6.4

3.9

66.72

135.37

e6/l

3.42

872

4532

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

595

2489

3.00

99.53

2.3

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

797

3945

2.72

96.25

6.4

3.7

83.88

84.31

0.17

775

3849

(21491868) Cryoglobulin [Mass/volume] in Serum

15.35

95.13

1.5

1.3

1.42

0.07

g/l

—

(3004809) Band form neutrophils/Leukocytes in Blood

139

195

7.60

94.85

4.4

2.3

1.66

1.45

0.20

122

158

(3013826) Glucose [Moles/volume] in Serum or Plasma

1514

10352

3.03

94.45

10.5

4.7

6.71

6.88

mmol/l

2.82

1477

9845

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

262

665

4.39

94.44

2.0

1.9

38.36

39.00

u/l

0.17

220

566

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

321

946

3.86

94.29

2.6

1.4

3.50

2.72

ug/l

1.60

260

716

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1697

12435

3.71

92.82

9.3

4.6

30.19

13.01

mm/h

108.91

1617

11544

(36304419) Bacteria [Presence] in Urine

880

4639

2.63

92.71

5.0

3.1

2134.38

0.90

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

908

4877

2.60

91.78

4.6

2.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

376

1253

3.48

91.64

2.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

12.90

91.11

1.6

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

12.90

91.11

1.6

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

264

693

4.25

90.91

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

797

4050

2.63

89.95

3.7

2.6

4.03

5.19

e6/l

2.13

737

3657

(3011412) CD3 cells [#/volume] in Blood

12.55

89.58

2.5

2.1

1351.00

1164.76

e6/l

0.60

(3032080) INR in Blood by Coagulation assay

1338

8715

2.68

89.23

23.9

19.7

1.34

1.37

inr

1.05

1170

7318

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1164

7095

2.58

89.20

4.5

2.5

—

estimate

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

449

1706

3.12

87.82

3.7

2.1

9.01

8.05

umol/l

0.29

385

1487

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

150

251

6.39

86.72

1.1

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

258

692

4.14

86.13

1.9

1.8

6.21

7.52

iu/ml

0.39

155

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1109

6685

2.52

85.83

4.5

3.3

2165.30

1616.25

ng/l

2.01

1016

5812

(3026782) Osmolality of Urine

701

3434

2.62

84.21

4.3

2.8

495.60

529.80

mosm/kgh2o

5.16

630

2970

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

721

3586

2.60

83.87

4.2

2.2

2.48

2.45

mmol/l

8.89

648

3156

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1224

7799

2.52

82.78

3.6

2.4

80.45

79.38

nmol/l

0.67

1119

6827

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

181

381

5.13

81.77

2.2

1.4

—

(40768804) Tissue Pathology biopsy report

881

4901

2.45

79.56

2.5

1.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

19.37

79.01

2.0

1.4

224.50

40.00

titre

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

14.00

78.70

2.3

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

175

371

5.08

78.35

2.1

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

729

3744

2.51

78.15

2.1

1.8

1259.82

1157.93

nmol/l

1.69

569

2814

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

133

220

6.41

77.66

1.5

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

166

341

5.23

77.04

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

221

576

4.20

76.40

3.6

2.8

0.29

0.36

iu/ml

2.24

127

340

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

393

4.88

75.92

2.2

2.1

12.23

mg/l

0.00

161

365

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1300

8766

2.43

73.68

3.0

2.3

95.99

94.14

pmol/l

0.69

802

4536

(3017732) Neutrophils [#/volume] in Blood

463

1988

2.74

70.83

4.0

2.8

4.16

4.79

e9/l

1.38

388

1653

(40758558) Short blood count panel - Blood

836

4733

2.34

70.29

11.9

4.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

363

1375

3.01

70.11

11.9

3.2

1.22

1.23

mmol/l

0.29

350

1158

(3036481) Cortisol [Moles/volume] in Serum or Plasma

377

1459

2.96

70.06

2.2

1.8

355.57

367.96

nmol/l

0.52

351

1319

(3035933) Granulocytes/Leukocytes in Blood

142

278

5.43

69.45

4.1

2.9

56.27

58.81

1.20

142

278

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

114

184

6.52

68.10

1.5

1.3

132.35

159.15

au/ml

1.18

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

701

3728

2.37

67.58

4.3

2.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1512

11167

2.55

66.08

7.2

4.9

2961.78

2506.02

e6/l

0.10

169

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

196

519

4.08

66.06

1.3

1.4

13.66

17.02

iu/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

357

1385

2.93

65.75

2.3

2.0

0.19

g/l

0.92

321

1257

(3000991) Gas panel - Venous blood

389

1588

2.81

65.11

11.0

7.7

—

(3035715) Granulocytes [#/volume] in Blood

125

232

5.69

64.74

4.1

3.1

3.80

4.35

e9/l

1.71

125

232

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

243

768

3.47

63.16

2.3

1.7

2.69

1.62

ug/l

0.75

213

668

(3042936) Bacteria identified in Isolate by Culture

511

2423

2.50

62.92

2.4

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

246

5.31

59.66

2.4

1.4

—

(40768446) Kidney Pathology biopsy report

11.87

58.67

1.4

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1276

8993

2.20

58.41

5.7

4.0

0.00

estimate

0.50

341

1821

(1616796) Gas panel - Central venous blood

156

382

4.35

58.22

5.5

4.1

—

(3002256) Pathology report gross observation

310

1185

2.92

58.21

1.5

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

340

4.56

58.09

1.6

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

147

6.67

57.82

4.8

2.4

54.31

59.81

1.30

115

(3009261) Glucose [Presence] in Urine by Test strip

1291

9180

2.19

57.21

5.8

4.1

0.01

estimate

0.18

326

1732

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

547

2776

2.35

57.14

4.7

3.1

2.12

2.39

e6/l

0.28

287

1365

(3012544) pH of Venous blood

447

2081

2.49

56.58

6.1

3.4

7.37

7.38

0.83

276

1204

(21494814) CD8 cells/Lymphocytes in Specimen

16.38

56.51

1.9

3.0

40.02

23.93

5.04

(3035350) Ketones [Presence] in Urine by Test strip

1283

9125

2.17

56.48

5.8

4.0

12.58

3.64

estimate

0.63

356

1888

(3026008) Bacteria identified in Urine by Culture

910

5685

2.12

56.43

4.4

3.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

118

236

5.26

56.23

1.6

1.8

0.63

0.96

g/l

1.61

191

(3002032) Base excess in Venous blood by calculation

433

2001

2.49

55.59

6.3

3.4

1.58

1.92

mmol/l

1.01

386

1745

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

195

579

3.63

55.56

1.5

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

437

2053

2.45

53.97

6.3

3.3

5.86

5.84

kpa

0.19

424

1992

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

575

3053

2.25

53.42

4.4

3.0

1.10

1.33

e6/l

0.49

326

1654

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

77.45

53.29

2.0

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

643

3580

2.18

53.02

2.2

1.6

1.51

1.36

mg/l

0.57

546

2800

(4062490) Immunoglobulin typing, IgG

142

6.44

52.49

1.7

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

197

613

3.46

52.16

1.4

1.2

3.48

0.65

u/ml

0.65

(3024139) IgG subclass 3 [Mass/volume] in Serum

143

6.40

52.13

1.7

1.4

0.47

0.40

g/l

0.40

108

(3027135) IgG subclass 1 [Mass/volume] in Serum

143

6.40

52.13

1.7

1.4

7.66

6.97

g/l

0.52

109

(3028192) IgG subclass 2 [Mass/volume] in Serum

143

6.40

52.13

1.7

1.4

2.79

3.00

g/l

0.29

108

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

181

5.71

52.01

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

294

4.59

51.74

1.6

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

10.85

51.64

3.0

1.4

768.37

420.89

e6/l

1.22

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

552

2917

2.24

51.61

1.4

1.3

51.75

35.92

iu/ml

1.10

181

877

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

605

3335

2.18

50.78

1.3

1.00

1.63

u/ml

1.89

136

842

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

10.45

50.34

2.4

2.3

39.37

46.21

1.27

(40768797) Stomach Pathology biopsy report

465

2311

2.33

50.16

1.3

1.2

—

(3015736) pH of Urine

1046

7157

1.99

47.71

4.6

3.6

6.25

6.28

0.34

498

3830

(3019832) Treponema pallidum Ab [Presence] in Serum

169

504

3.58

47.68

1.5

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

845

5392

2.00

46.90

3.0

2.4

59.92

61.88

u/l

0.39

786

4945

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

132

337

4.13

46.48

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

304

4.29

46.07

1.6

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

156

5.72

45.53

1.2

1.1

—

(3012501) Base excess in Blood by calculation

131

339

4.07

45.28

6.5

4.6

2.61

2.87

mmol/l

0.45

221

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

191

5.18

44.94

1.4

1.2

289.30

261.13

u/ml

0.30

108

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

797

5043

1.98

44.77

4.1

2.6

35.18

36.15

u/l

0.12

748

4695

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

154

451

3.62

44.60

2.1

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

197

5.07

44.36

1.9

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

289

1219

2.61

44.19

2.2

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1061

7419

1.94

44.06

5.9

4.3

97.72

98.89

ng/l

0.01

891

5762

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

927

6198

1.94

44.04

2.7

2.2

235.34

232.67

u/l

0.02

891

5824

(3048929) Epstein Barr virus Ab [Presence] in Serum

112

265

4.42

43.55

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

186

628

3.17

42.95

2.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

370

1779

2.33

42.42

5.7

3.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

437

2255

2.21

42.25

7.9

6.8

11.47

11.40

kpa

0.11

424

2166

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

437

2255

2.21

42.25

7.9

6.8

5.04

5.07

kpa

0.18

424

2167

(3014111) Lactate [Moles/volume] in Serum or Plasma

354

1676

2.36

42.02

8.6

6.6

1.35

1.43

mmol/l

0.62

348

1643

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

130

353

3.87

42.00

2.3

1.8

2074.64

370.87

u/ml

0.58

109

283

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

215

4.75

41.84

1.1

1.0

—

(3019977) pH of Arterial blood

434

2247

2.20

41.54

8.0

6.8

7.42

1.11

229

1294

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1821

15759

3.18

41.16

43.2

16.3

25.22

25.70

mg/l

0.25

1728

12970

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

104

243

4.46

41.08

1.7

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

471

3.44

41.00

1.6

1.5

0.26

6.51

iu/ml

0.49

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

7.54

40.39

1.2

92.60

80.20

—

(3036489) Thrombin time

160

516

3.29

39.80

2.7

1.7

21.78

20.64

1.78

152

457

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

133

384

3.64

39.29

1.1

1.2

84.00

380.00

titre

—

(3003396) Base excess in Arterial blood by calculation

426

2234

2.16

39.24

8.0

6.8

1.08

1.13

mmol/l

0.08

369

1834

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

495

2756

2.06

38.89

1.4

1.3

19.60

12.97

u/ml

0.63

146

996

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1279

9742

1.90

38.51

4.1

3.2

63.79

50.81

u/l

3.02

1186

8901

(3016502) Oxygen saturation in Arterial blood

394

2019

2.19

38.39

8.2

6.9

94.71

94.95

0.25

384

1946

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

239

982

2.63

38.30

1.3

34.16

57.40

au/ml

1.50

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

102

251

4.23

37.67

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

252

1082

2.52

36.81

2.6

2.5

22.35

19.68

au/ml

0.17

(3022145) Colonoscopy Study observation

339

1678

2.23

35.79

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

625

3872

1.90

35.54

6.0

4.4

183.40

448.31

ng/l

3.14

556

3334

(3014051) Protein [Presence] in Urine by Test strip

716

4634

1.86

35.49

4.0

3.2

0.05

0.04

0.01

158

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

304

1451

2.30

34.97

2.7

2.1

34.78

38.85

u/l

0.78

255

1184

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

6.79

34.93

2.4

2.2

17.14

51.60

iu/ml

0.99

(44790049) Parainfluenza type 3 nucleic acid detection

189

4.60

34.76

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

189

4.60

34.76

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

189

4.60

34.76

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

189

4.60

34.76

1.8

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1069

7843

1.80

34.72

3.0

2.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

381

2010

2.11

34.08

2.1

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

129

404

3.35

33.57

1.4

1.2

4.90

5.39

u/ml

0.05

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

149

4.98

32.93

1.2

55.25

52.54

u/l

0.22

129

(40768443) Skin Pathology biopsy report

178

681

2.77

32.66

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

140

470

3.13

32.49

1.4

1.2

2.97

3.03

u/ml

0.02

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

144

492

3.08

32.43

1.4

1.2

26.45

52.21

u/ml

0.80

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

115

5.53

32.04

1.8

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

10.17

31.87

3.4

1.7

1.69

1.36

0.23

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

226

985

2.46

31.79

1.7

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

139

471

3.10

31.75

1.4

1.3

3.41

3.59

u/ml

0.07

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

150

4.87

31.70

1.5

1.3

178.90

266.91

u/l

1.54

142

(3010838) Calcium [Moles/time] in 24 hour Urine

104

294

3.68

31.65

2.0

2.1

4.39

4.78

mmol/24h

0.56

252

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

5.22

31.46

5.3

2.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

188

758

2.64

31.10

2.9

2.1

854.06

941.23

ug/l

0.08

175

717

(3052851) Hemolysis interference index of Serum or Plasma

133

445

3.13

31.03

3.7

3.5

3.49

1.80

index

0.40

214

(3009343) pH of Capillary blood

261

1234

2.29

30.48

4.9

3.6

7.41

0.04

228

1017

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

266

1274

2.26

30.10

5.0

3.6

5.14

5.19

kpa

0.37

255

1208

(3007566) Smooth muscle Ab [Titer] in Serum

126

418

3.15

29.82

1.3

1.1

186.67

103.55

titre

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

127

5.09

29.70

1.8

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

128

431

3.11

29.53

1.2

1.1

738.00

1810.77

titre

—

(3003434) Protein [Mass/volume] in Pleural fluid

240

3.84

29.00

1.7

1.5

29.88

27.41

g/l

0.91

212

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

144

4.71

28.36

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

336

1810

2.03

27.95

3.6

3.2

300.93

232.06

ng/l

1.44

305

1674

(40761536) Microorganisms panel - Urine sediment

251

1209

2.23

27.92

7.1

4.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

206

4.01

27.79

1.1

—

(40768800) Prostate Pathology biopsy report

5.59

27.79

1.1

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

326

1743

2.04

27.67

4.7

2.8

4.70

4.45

kpa

1.11

315

1687

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

231

1080

2.29

27.59

5.0

3.4

2.27

2.06

mmol/l

0.33

172

774

(3012441) Differential panel - Pleural fluid

169

4.32

27.38

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

122

4.96

27.02

1.2

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

271

1366

2.14

26.86

4.0

2.4

45.97

61.92

ml/min/173m2

12.72

173

573

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1483

12415

1.80

26.64

5.0

4.2

15.01

15.04

pmol/l

0.21

1360

11196

(40768806) Pleura Pathology biopsy report

149

4.48

26.30

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

10.50

26.26

1.4

1.1

—

(40758292) HTLV I+II Ab panel - Serum

37.26

26.18

1.4

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

118

4.95

26.07

2.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

118

4.95

26.07

2.6

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

118

4.95

26.07

2.6

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

387

3.07

25.92

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

387

3.07

25.92

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

590

3885

1.74

25.85

1.5

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

143

4.52

25.80

2.8

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

132

4.66

25.54

2.8

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

145

4.46

25.36

1.4

1.1

—

(4212803) Bone marrow aspirate examination

36.11

25.24

1.1

1.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1724

15245

2.08

24.86

39.8

16.0

67.84

73.40

ml/min/173m2

20.02

1676

14131

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.72

24.70

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

161

4.21

24.66

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

6.00

24.37

2.6

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

107

363

3.06

24.36

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

102

337

3.14

24.29

1.3

1.2

34.18

61.30

u/ml

—

(3049717) Cytology report of Urine Cyto stain

147

594

2.59

24.11

2.8

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

634

4333

1.68

23.86

5.0

3.9

0.29

0.11

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

235

3.51

23.00

5.0

6.4

11.85

12.76

mg/l

1.11

222

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

102

349

3.03

22.88

1.4

1.3

73.84

33.64

e6/l

0.28

265

(40759836) Histone Ab [Presence] in Serum by Immunoblot

137

4.33

22.61

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

125

4.50

22.51

1.0

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

121

4.56

22.49

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

102

354

2.98

22.32

1.4

1.3

316.18

607.49

e6/l

0.39

283

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

114

4.66

22.24

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

221

3.54

22.20

3.0

3.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1826

16656

2.40

22.06

48.4

20.9

4.01

mmol/l

0.55

1817

16271

(3019550) Sodium [Moles/volume] in Serum or Plasma

1824

16632

2.38

22.02

46.4

20.7

139.02

139.78

mmol/l

28.18

1815

16275

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

4.16

21.85

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1690

14996

1.92

21.80

6.4

5.3

1.98

2.03

mu/l

0.87

1570

13630

(3004119) Hemoglobin [Mass/volume] in Venous blood

251

1326

2.02

21.72

4.3

3.0

118.25

130.42

g/l

14.41

239

1283

(3039162) Centromere protein B Ab [Units/volume] in Serum

199

3.61

21.16

1.3

46.34

101.84

u/ml

—

(3048689) Calprotectin [Mass/mass] in Stool

313

1798

1.88

21.15

2.1

2.2

128.16

168.15

ug/g

1.77

261

1423

(3023199) Leukocytes [#/volume] in Pleural fluid

204

3.57

21.12

1.7

1.5

930.44

1508.28

e6/l

1.12

144

(3012516) Albumin [Mass/volume] in Urine

904

6893

1.58

21.09

4.6

3.5

118.95

47.23

mg/l

6.17

668

4440

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.73

20.84

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

124

496

2.60

20.75

1.5

1.4

268.06

291.75

ug/g

0.60

314

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

4.24

20.55

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

644

4555

1.62

20.52

5.7

3.6

0.92

0.37

estimate

0.25

274

1418

(3009508) Creatinine [Moles/volume] in Urine

910

6980

1.57

20.48

4.5

3.4

6.48

7.24

mmol/l

7.78

789

5819

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

135

4.16

20.41

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

4.16

20.41

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

336

1998

1.82

20.27

1.7

1.4

—

(3019060) Gas panel - Arterial blood

229

1207

2.02

19.88

4.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

600

4198

1.62

19.86

2.0

1.8

48660243.29

35253276.68

pmol/l

0.14

485

3421

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1817

16648

2.24

19.85

26.1

11.0

24.35

24.93

u/l

0.66

1796

15960

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

100

369

2.80

19.59

1.3

1.2

3.81

3.95

mmol/l

0.78

343

(3000060) B lymphocytes [#/volume] in Blood

24.85

19.54

2.8

1.7

0.07

0.25

e9/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.63

19.19

1.7

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

5.45

19.04

1.4

1.2

0.51

0.48

ratio

0.40

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.91

18.75

1.7

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

906

7034

1.54

18.73

5.5

4.2

26.19

8.34

mg/mmol

8.11

637

4392

(3028308) Erythrocytes [#/volume] in Pleural fluid

177

3.58

18.64

1.7

1.5

16311.16

75995.60

e6/l

0.88

(3005322) IgE [Units/volume] in Serum or Plasma

188

949

2.09

18.32

1.6

1.3

189.19

252.19

u/ml

0.63

178

881

(3045788) Cell count panel - Pleural fluid

170

3.61

18.25

1.8

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

126

541

2.42

18.15

1.5

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.77

18.07

3.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.77

18.07

3.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.77

18.07

3.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.77

18.07

3.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

380

2.69

17.99

2.9

2.3

35.04

33.21

umol/l

0.27

339

(36660697) Celiac disease serology panel - Serum

223

1205

1.96

17.98

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

191

977

2.06

17.96

2.6

2.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1830

16922

2.22

17.74

53.0

22.0

100.54

82.75

umol/l

22.47

1824

16678

(3006184) Hemoglobin [Mass/volume] in Capillary blood

116

485

2.48

17.71

3.6

2.1

118.70

130.73

g/l

5.75

390

(3024928) Oxygen saturation in Venous blood

118

500

2.45

17.50

3.4

2.7

57.21

59.94

0.61

112

482

(40765096) Chromosome analysis panel by Banding

13.23

17.44

1.2

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

4.50

17.32

1.1

335.35

267.73

mg/l

1.19

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

4.58

17.31

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

100

4.37

17.14

1.3

1.1

50.05

36.92

mg/l

1.11

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.66

17.04

2.8

2.5

912.00

4752.86

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

203

3.28

17.03

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

194

3.32

16.88

1.2

4.30

3.05

u/ml

0.22

(3023419) Bacteria identified in Sputum by Culture

284

2.89

16.85

3.1

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

336

2.73

16.71

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

211

3.20

16.65

1.9

1.8

18.99

31.76

u/ml

0.89

193

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.52

16.61

1.8

1.3

—

(3019225) pH of Specimen

292

1763

1.77

16.52

11.3

3.7

7.38

7.36

2.33

246

1139

(3003181) Sodium [Moles/volume] in Urine

375

2.61

16.35

1.3

1.4

53.97

59.77

mmol/l

1.01

302

(3007461) Platelets [#/volume] in Blood

1832

17040

2.14

15.96

61.9

24.6

241.51

240.49

e9/l

0.21

1818

16576

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1832

17040

2.14

15.96

61.6

24.5

93.84

91.76

46.39

1826

16772

(3035941) MCH [Entitic mass]

1832

17041

2.14

15.94

61.5

24.5

30.90

30.50

13.37

1825

16774

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.45

15.92

1.2

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

1832

17042

2.14

15.92

61.7

24.5

4.05

4.45

e12/l

140.95

1812

16496

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1832

17042

2.14

15.92

62.8

25.0

37.28

40.13

87.55

1825

16771

(3010813) Leukocytes [#/volume] in Blood

1832

17042

2.14

15.92

61.8

24.6

6.89

6.82

e9/l

0.60

1813

16496

(3000963) Hemoglobin [Mass/volume] in Blood

1832

17044

2.14

15.88

62.3

24.7

123.18

134.80

g/l

154.05

1824

16781

(3030981) Hyaline casts [#/volume] in Urine by Automated count

265

1573

1.79

15.85

2.9

2.3

0.36

0.49

e6/l

0.53

260

1501

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

4.25

15.79

1.5

1.4

5.31

6.78

u/l

0.74

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.25

15.79

4.1

4.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

22.23

15.54

2.6

1.0

28.42

18.15

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

111

483

2.38

15.54

1.6

1.2

—

(3035880) pH of Pleural fluid

4.38

15.24

1.2

1.3

7.39

7.43

0.34

(3025941) Bacteria identified in Stool by Culture

152

759

2.09

15.22

1.4

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

326

2.65

14.97

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

164

3.36

14.82

1.4

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.32

14.57

1.7

1.4

4.16

7.08

u/l

0.66

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

118

3.79

14.53

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

4.71

14.48

1.1

0.94

1.14

u/l

2.33

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

852

6767

1.46

14.46

6.2

4.1

0.01

0.09

estimate

0.58

292

1471

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.02

14.33

2.2

571.56

1176.50

e6/l

0.47

(3029937) Albumin [Presence] in Urine by Test strip

678

5161

1.48

14.27

6.5

4.1

0.00

estimate

0.50

296

1659

(3023410) Appearance of Cerebral spinal fluid

149

3.42

14.14

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

125

3.66

14.14

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

4.38

14.06

1.2

1.1

101.53

88.55

u/l

0.38

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

4.33

13.85

1.2

1.1

26.03

27.15

u/l

0.05

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

155

809

1.99

13.75

3.2

3.0

4.13

4.43

pmol/l

3.36

144

697

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.53

13.65

2.3

1.9

4579.00

68404.18

e6/l

0.51

(3004616) Nuclear Ab [Presence] in Serum

228

2.87

13.44

1.6

1.2

—

(3033799) Differential panel - Peritoneal fluid

6.11

13.40

2.1

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

3.80

13.28

1.7

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

179

995

1.88

13.17

4.8

3.1

25.66

25.24

mmol/l

0.64

173

952

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

172

3.14

13.10

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.96

13.06

3.7

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.96

13.06

3.7

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.96

13.06

3.7

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

119

3.58

12.84

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.81

12.74

1.2

14.97

14.14

g/l

0.14

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

176

3.07

12.61

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.05

12.39

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.39

12.30

1.5

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

191

2.93

12.12

1.2

4.71

8.33

u/ml

0.68

(3008152) Bicarbonate [Moles/volume] in Arterial blood

213

1280

1.74

12.11

6.1

6.3

24.95

24.51

mmol/l

0.66

206

1231

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

134

3.34

12.07

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

3.67

12.06

1.7

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

176

3.01

11.99

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.81

11.75

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

3.04

11.53

1.6

1.3

—

(3004451) EKG impression Narrative

130

3.28

11.25

1.2

1.3

—

(40768793) Breast Pathology biopsy report

3.84

11.21

1.3

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

146

3.13

11.16

1.1

—

21.90

—

(3000475) Leukocytes [#/volume] in Synovial fluid

104

511

2.09

10.90

1.8

1.5

15435.55

14489.85

e6/l

0.07

365

(3024869) Neuronal Ab [Presence] in Serum

5.43

10.88

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

221

1389

1.67

10.63

1.7

1.64

1.57

0.62

179

1161

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.16

10.62

1.9

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.16

10.62

1.9

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

156

3.00

10.60

4.2

2.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

10.42

1.0

0.0

—

(3044007) Cell count panel - Peritoneal fluid

5.45

10.40

2.4

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

220

2.64

10.35

3.2

3.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

127

3.19

10.30

1.4

1.6

27.39

20.38

ng/l

0.95

127

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.74

10.24

1.6

1.5

0.33

0.37

ug/l

0.15

(44816559) Phosphatidylethanol [Mass/volume] in Blood

113

586

1.99

10.23

1.7

1.4

0.33

mg/l

0.00

251

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.84

10.22

1.7

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

847

7014

1.37

10.06

5.8

4.4

2.35

2.11

ug/l

0.78

750

6296

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

140

3.04

9.98

1.5

—

1853.33

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

4.17

9.90

1.2

1.4

68.67

60.22

0.53

(40768441) Liver Pathology biopsy report

4.28

9.85

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1681

15631

1.53

9.66

8.5

7.5

40.52

40.51

mmol/mol

0.00

1570

14455

(3006653) Thiamine [Moles/volume] in Blood

3.48

9.48

1.0

1.2

133.53

140.27

nmol/l

0.38

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.77

9.33

1.3

3.4

56.37

60.59

mg/l

0.17

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

13.73

9.18

1.2

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

154

2.83

9.04

3.6

3.4

13.50

11.93

index

0.51

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

129

729

1.82

9.03

3.1

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

200

2.59

9.01

1.8

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.98

8.85

1.6

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.64

8.79

2.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

122

685

1.83

8.73

2.5

1.7

—

(3022313) Gas panel - Capillary blood

145

858

1.75

8.70

5.2

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

186

2.62

8.70

1.8

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1696

15880

1.50

8.59

6.4

5.8

6.07

6.10

mmol/l

0.34

1558

14366

(3005988) Vibrio sp identified in Specimen by Organism specific culture

188

2.59

8.52

1.8

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

172

1074

1.66

8.47

2.4

2.2

12.43

15.01

nmol/l

3.16

145

963

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

20.11

8.47

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

107

582

1.89

8.46

1.7

1.6

39.37

24.13

u/ml

0.58

(3044941) Cell count panel - Synovial fluid

360

2.13

8.41

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

197

2.53

8.26

1.8

1.2

—

(3045424) Erythrocytes [Presence] in Urine

142

851

1.72

8.15

2.5

2.0

0.06

0.98

estimate

0.46

255

(3024522) Salmonella sp identified in Specimen by Organism specific culture

199

2.50

8.09

1.8

1.2

—

(4281824) Cell count and differential, peritoneal fluid

3.41

8.08

1.3

1.1

—

(3047181) Lactate [Moles/volume] in Blood

107

591

1.86

8.08

5.4

5.2

1.29

1.37

mmol/l

0.23

526

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

6.84

8.06

1.7

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

142

2.78

7.98

1.3

88.08

101.04

pmol/l

0.86

142

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

121

2.93

7.87

1.0

302.41

288.32

mg/l

0.45

106

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.80

7.80

1.1

1667.70

1654.84

miu/ml

0.02

(3025468) Yersinia sp identified in Specimen by Organism specific culture

186

2.51

7.68

1.8

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

6.72

7.58

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

252

1767

1.49

7.48

2.5

2.0

0.06

0.01

estimate

0.48

336

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.14

7.48

1.5

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

4.42

7.43

1.8

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

113

652

1.78

7.42

5.6

3.9

24.65

24.78

mmol/l

0.19

104

587

(3042733) HLA Ab [Presence] in Serum

5.99

7.38

3.5

4.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

215

2.36

7.33

1.1

1.2

248.80

224.21

miu/ml

—

(37208534) Antinuclear antibody arbitrary concentration in serum

4.16

7.27

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

236

2.28

7.18

1.6

1.4

70.48

67.74

0.24

148

(3016750) Collection duration of Urine

111

2.91

7.17

2.2

2.0

503.05

498.14

min

0.08

(3003327) Ova and parasites identified in Stool by Light microscopy

447

1.92

7.14

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.63

7.06

2.1

2.5

0.60

0.61

mmol/l

0.36

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3.20

6.85

1.8

1.4

1.70

3226.37

u/l

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

139

872

1.64

6.75

5.5

4.5

0.87

0.85

0.14

134

829

(3003329) Lymphocytes/Leukocytes in Synovial fluid

169

2.46

6.62

1.6

1.4

31.54

25.99

0.49

109

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

500

4022

1.33

6.57

3.4

3.0

0.84

0.75

ug/l

0.98

373

2776

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

207

2.30

6.56

1.1

1.0

1.54

1.56

g/l

0.11

181

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

182

2.39

6.56

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

433

1.88

6.49

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.20

6.46

13.2

12.0

4.80

5.14

mmol/l

0.32

(3024471) HLA-A [Type]

6.20

6.46

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.41

6.41

1.0

1.2

—

(4195642) Thrombophilia screening test

178

2.39

6.40

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

242

2.18

6.38

1.6

1.3

0.18

0.39

nmol/l

—

(3011648) Oxygen content in Venous blood

197

2.31

6.38

2.2

1.8

8.72

10.36

1.71

197

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

197

2.31

6.38

1.5

1.3

0.20

nmol/l

0.16

165

(3014765) Yersinia sp identified in Stool by Organism specific culture

436

1.87

6.36

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

125

2.67

6.33

1.7

1.2

1.25

1.63

u/ml

0.13

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.60

6.32

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

11.05

6.29

1.5

2.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

438

1.86

6.27

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

18.07

6.26

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

6.25

1.0

0.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

+∞

6.25

1.8

0.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.22

6.15

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.71

6.03

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.18

6.02

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

3.18

6.02

1.6

6.2

—

71.72

—

(3011985) Renin [Units/volume] in Plasma

248

2.13

6.02

1.3

1.4

86.35

95.04

mu/l

0.07

224

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.19

6.01

1.4

1.1

80.27

75.27

0.23

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.36

6.00

1.6

1.3

92.75

141.37

nmol/l

1.20

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

145

947

1.57

5.99

5.4

4.3

1.55

1.61

0.44

139

901

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.70

5.92

1.2

1.3

2.11

7.16

ug/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

15.06

5.90

1.3

1.2

—

(4268621) Lupus anticoagulant assay

137

2.51

5.79

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

254

1871

1.41

5.79

2.5

5.76

7.61

ug/l

1.20

223

1628

(3008295) Osmolality of Serum or Plasma

187

2.27

5.76

1.5

271.39

272.90

mosm/kgh2o

0.14

134

(3000492) Spirometry study

196

1378

1.47

5.74

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

6.88

5.73

1.3

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1698

16138

1.39

5.71

6.7

6.6

2.39

2.54

mmol/l

9.39

1558

14807

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1597

15037

1.33

5.70

4.9

4.7

1.28

1.27

mmol/l

0.07

1451

13552

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.03

5.56

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.54

5.55

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

244

2.08

5.48

3.3

8.1

6.97

7.54

mmol/l

0.69

206

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.92

5.46

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.92

5.46

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

2.10

5.40

1.3

262.17

309.27

pmol/l

0.56

196

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.74

5.30

2.6

1.1

72.60

75.59

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1663

15795

1.35

5.26

5.9

5.7

4.27

4.44

mmol/l

8.79

1529

14534

(3024932) HLA-DR beta [Type]

5.42

5.22

1.1

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

3.15

5.19

1.4

1.3

147.50

170.89

mmol/24h

0.70

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

203

2.14

5.15

1.7

1.4

—

nmol/l

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

196

1409

1.43

5.12

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

104

653

1.63

5.09

3.9

3.8

1.71

1.45

mmol/l

0.62

640

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.47

5.05

1.5

1.1

98.81

96.43

0.08

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1650

15678

1.33

5.01

5.8

5.6

1.39

1.44

mmol/l

4.99

1505

14306

(3003740) Influenza virus B Ag [Presence] in Specimen

141

2.36

5.00

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

142

2.35

4.93

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.68

4.92

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.50

4.89

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

7.73

4.85

1.0

—

(3004775) Volume in Urine collected for unspecified duration

163

2.23

4.79

2.2

2.3

632.26

616.17

0.09

103

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.03

4.78

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.03

4.78

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.03

4.78

1.4

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.44

4.74

3.0

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.96

4.71

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.96

4.71

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.96

4.71

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.96

4.71

1.2

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

184

2.14

4.70

1.6

1.8

35.38

24.79

u/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

589

1.63

4.67

1.3

1.2

—

(3008898) HLA-B27 [Presence]

383

1.78

4.65

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

7.17

4.65

1.2

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

2.39

4.40

2.2

1.9

113.61

112.29

ng/l

0.02

118

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

3.35

4.32

1.1

1.2

4.30

15.51

pmol/l

—

(3014891) Appearance of Pleural fluid

5.02

4.31

1.8

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

8.92

4.28

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

8.92

4.28

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

349

1.77

4.25

1.1

—

4.05

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.15

4.21

1.1

1.7

87.39

67.92

nmol/24h

0.48

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.87

4.19

1.0

1.2

0.67

0.71

umol/24h

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.87

4.19

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

655

5700

1.22

4.18

4.8

4.1

23.39

24.37

0.79

354

2869

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.95

4.16

1.1

0.03

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

201

2.01

4.13

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

4.36

4.12

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.03

4.06

2.9

3.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.64

4.05

1.7

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.77

4.02

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.02

4.00

2.5

2.1

3.18

6.50

ug/l

1.54

(3016038) Potassium [Moles/volume] in Urine

143

2.19

3.99

1.0

1.2

31.71

34.37

mmol/l

0.30

123

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.58

3.97

1.7

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

2.49

3.97

1.3

1.4

1.80

1.60

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

118

812

1.48

3.91

1.2

56.06

127.23

u/ml

2.05

312

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.08

3.90

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

7.30

3.86

1.3

1.0

—

(3017569) Oxygen content in Arterial blood

139

2.18

3.84

2.0

1.9

14.80

16.53

2.17

139

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

509

1.60

3.79

2.9

2.3

170.47

89.55

ug/min

0.76

300

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.70

3.66

1.2

2.3

1.86

8.22

nmol/l

1.24

(3022621) pH of Urine by Test strip

192

1460

1.35

3.63

3.1

3.0

5.96

6.05

0.75

140

1031

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

7.80

3.56

1.0

1.1

18.00

20.52

iu/ml

—

(44806071) Cardiolipin IgM antibody measurement

6.17

3.50

1.1

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

10.03

3.50

1.5

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

528

1.56

3.49

3.6

3.4

0.84

0.83

nmol/l

0.04

423

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

222

1.86

3.46

1.9

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

352

1.67

3.35

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.73

3.32

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

3.44

3.31

1.8

1.4

8.00

27.14

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.42

3.30

2.9

1.6

2.93

2.56

u/field

0.08

(3036670) Protein [Mass/volume] in Synovial fluid

2.63

3.30

1.1

1.2

39.27

38.50

g/l

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.93

3.30

1.2

1.3

2.34

1.93

umol/l

0.76

(3052592) Norovirus Ag [Presence] in Stool

3.94

3.28

1.3

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

371

1.64

3.23

1.8

4.38

20.09

iu/l

0.46

140

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.48

3.13

1.2

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

7.52

3.05

1.2

1.1

234.33

236.63

nmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

161

1.94

3.00

2.4

2.1

1.53

1.51

u/field

0.01

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.30

2.99

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.25

2.96

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.44

2.88

1.1

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

136

2.00

2.85

1.0

2.14

2.35

eliau/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.17

2.85

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

150

1144

1.34

2.83

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

116

2.08

2.83

1.7

1.9

—

(3009871) Measles virus Ab [Titer] in Serum

2.78

2.81

1.8

1.5

3168.00

4906.67

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.35

2.81

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

213

1708

1.28

2.78

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.35

2.75

3.0

3.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

205

1.77

2.66

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

3.07

2.56

1.1

1.3

—

(3033099) Centromere Ab [Titer] in Serum

3.07

2.56

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

7.16

2.55

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.47

2.54

1.5

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.61

2.53

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

2.28

2.51

1.5

1.1

11.54

9.42

umol/l

0.17

(3009214) Lutropin [Units/volume] in Serum or Plasma

217

1.72

2.49

1.2

1.3

8.71

8.58

u/l

0.02

174

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.39

2.47

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

2.68

2.45

1.5

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.68

2.45

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.13

2.36

1.0

—

(3000330) Specific gravity of Urine by Test strip

132

1019

1.32

2.33

4.9

3.5

1.02

ratio

1.81

114

938

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

2.03

2.26

1.9

2.1

18.40

131.25

ug/min

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

5.57

2.21

1.0

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

5.57

2.21

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

136

1.85

2.18

3.0

2.9

31.11

31.67

mg/l

0.02

104

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

707

0.66

2.18

1.6

1.9

3.12

3.46

mmol/l

0.82

542

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

674

1.37

2.14

1.5

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

160

1.76

2.10

1.1

1.3

—

(3026480) Teichoate Ab [Titer] in Serum

4.01

2.04

1.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1330

12723

1.14

2.01

53.5

21.5

329.15

331.76

g/l

19.19

1325

12652

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

170

1.72

2.00

1.1

—

2.21

—

(3028707) Methadone [Presence] in Urine by Screen method

2.09

1.96

1.8

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.20

1.94

1.1

1.2

108.20

125.53

ng/l

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.57

1.94

1.1

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.45

1.93

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

981

0.73

1.85

2.3

2.2

3.44

3.46

ratio

0.03

809

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.54

1.84

1.0

1.1

1.87

1.83

umol/24h

—

(4024509) Urine culture

121

958

1.28

1.83

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.01

1.80

1.1

8.14

11.57

iu/ml

—

(4133840) Spirometry

2.67

1.72

1.3

1.1

—

(3024263) Appearance of Synovial fluid

103

1.85

1.71

1.9

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.30

1.70

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

406

0.61

1.69

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

668

1.32

1.67

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.16

1.66

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.81

1.65

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.45

1.64

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.96

1.59

1.4

1.6

74.14

105.67

umol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

1.58

1.0

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.28

1.55

2.6

1.1

79.90

114.00

—

(3019150) Specific gravity of Urine by Refractometry

463

4209

1.13

1.52

6.1

4.3

1.02

kg/l

0.00

350

2765

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.34

1.52

1.6

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.86

1.50

1.5

1.1

57.50

63.19

ug/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

360

1.40

1.47

2.3

1.4

0.87

0.81

nmol/l

0.24

294

(3008037) Lactate [Moles/volume] in Venous blood

543

1.32

1.44

5.3

2.9

1.64

1.67

mmol/l

0.09

526

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.13

1.44

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.73

1.43

2.7

1.4

36.67

49.73

umol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

491

1.33

1.43

1.2

1.1

—

(3034426) Prothrombin time (PT)

2.31

1.43

1.2

1.4

26.33

28.64

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

133

1.66

1.42

1.7

1.3

0.76

1.12

promille

0.50

103

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.95

1.36

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

120

1.67

1.34

1.5

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.30

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.10

1.30

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

318

1.39

1.29

1.3

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.78

1.28

1.4

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.29

1.27

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

2.05

1.27

5.2

1.3

21.22

9.07

mm/h

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.23

1.24

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

108

1.67

1.22

2.7

1.7

141.61

90.61

umol/l

1.02

108

(3011288) Drugs identified in Urine by Screen method Nominal

101

1.69

1.20

2.2

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

447

0.71

1.12

1.2

1.8

8.24

4.04

mg/l

0.82

331

(3016244) Insulin [Units/volume] in Serum or Plasma

1.90

1.12

3.2

3.4

42.45

23.19

mu/l

0.24

(3010144) Erythrocytes [#/volume] in Synovial fluid

184

1.47

1.11

1.8

1.3

283829.20

172895.07

e6/l

0.17

126

(1761482) Bacteria [#/volume] in Urine by Culture

486

1.28

1.10

6.3

4.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.38

1.09

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.87

1.07

3.6

1.4

6.75

7.94

mmol/l

0.39

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.65

1.06

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.65

1.06

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.93

1.06

1.2

1.5

9.31

9.37

ug/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

252

0.63

1.03

1.5

1.2

1.47

1.54

g/l

0.66

252

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.96

1.03

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.77

1.00

1.0

1.4

0.26

0.23

nmol/l

—

(44806420) Estimation of glomerular filtration rate

134

1.50

0.91

2.3

2.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.15

0.91

2.2

2.8

—

61.70

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.67

0.91

1.3

47.69

37.09

u/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

126

1.51

0.91

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.91

0.88

1.1

1.3

—

(3020650) Glucose [Presence] in Urine

1.78

0.84

1.4

2.2

0.00

0.13

estimate

—

(3016879) Cocaine [Presence] in Urine

147

1.43

0.80

1.6

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

156

1.41

0.79

1.0

287.88

335.53

ng/l

0.55

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.70

0.75

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.57

0.75

2.3

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

158

1.40

0.74

1.0

38.59

45.61

ng/l

0.59

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

158

1.40

0.74

1.0

932.18

635.72

ng/l

1.49

(1002224) Polysomnography panel

525

1.21

0.73

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

101

1.49

0.70

1.1

0.71

1.18

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

175

1582

1.12

0.70

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

152

1.39

0.69

1.6

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

110

1.46

0.68

1.1

0.12

0.43

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

240

1.30

0.67

1.8

2.3

25.80

19.04

mg/l

—

(3027008) Opiates [Presence] in Urine

153

1.38

0.67

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

154

1.37

0.65

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

1.45

0.62

2.5

2.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.5

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

248

1.25

0.55

1.2

1.1

1.11

53.45

iu/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

267

1.24

0.54

2.1

1.7

—

(3020491) Glucose [Moles/volume] in Blood

134

1.35

0.53

1.6

3.1

7.26

6.97

mmol/l

0.23

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.52

0.52

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.46

0.50

1.7

1.5

1.13

1.17

mmol/l

—

(3005570) Glucose [Moles/volume] in Urine

189

1.27

0.49

2.0

2.1

—

(21494755) Public health laboratory ask at order entry panel

647

0.86

0.49

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

110

1.37

0.48

4.1

3.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.52

0.48

7.9

7.14

5.25

kpa

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

726

7047

1.05

0.45

2.2

2.0

1.33

1.30

mmol/l

0.39

597

5793

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.43

0.45

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.40

0.44

1.8

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.37

0.43

1.0

1.1

3.22

2.03

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

166

1.27

0.43

1.1

0.96

0.72

u/ml

0.14

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.40

0.0

1.1

—

9.88

—

(4015189) Microbial culture of sputum

1.33

0.40

5.9

2.2

—

(3027944) Amphetamines [Presence] in Urine

150

1.27

0.40

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

402

1.15

0.37

4.3

3.8

28.16

29.69

mg/l

0.13

283

(44813793) Dust mix specific IgE antibody measurement

1.34

0.35

1.0

—

(40757373) Influenza virus identified in Isolate

1.43

0.35

1.3

1.5

—

(4034850) Laboratory test

595

0.89

0.34

14.9

10.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

165

1.21

0.31

2.1

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

219

2293

0.95

0.29

5.8

5.5

33.86

33.50

0.16

151

1457

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

255

0.86

0.24

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

486

1.09

0.23

1.8

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.25

0.22

1.4

1.2

17.85

17.96

umol/l

0.00

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

240

1.13

0.20

2.8

—

(1761868) Lipid panel - Serum or Plasma

522

5120

1.03

0.19

3.7

3.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.17

0.17

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

544

1.07

0.16

1.9

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.08

0.14

1.3

1.4

134.98

153.66

pmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

134

1.12

0.11

1.0

1.1

0.72

3.08

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

194

1.08

0.09

2.2

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.14

0.08

1.0

1.1

0.22

0.26

u/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

128

1.09

0.06

1.9

1.7

7.91

8.32

mmol/l

0.13

128

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

228

2311

0.98

0.06

11.6

7.2

—

(4211845) Urine protein measurement

102

1.08

0.03

1.6

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

132

1.06

0.02

1.0

1.1

2.72

0.94

u/ml

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.8

—

2.90

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.02

-0.00

1.0

1.1

—

2.27

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

62.14

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.2

—

7.52

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3006462) Nitrate [Presence] in Urine

0.95

-0.00

1.7

3.8

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

30.24

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MGUS_WIDE – Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo (C3_MGUS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints